Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma

Risk SNP-mediated enhancer-promoter interaction drives colorectal cancer through both FADS2 and AP002754.2

(2020) Jianbo Tian et al.   CANCER RESEARCH

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma

(2020) Dina Guo et al.   Journal of Translational Medicine

B cells and tertiary lymphoid structures promote immunotherapy response

(2020) Beth A. Helmink et al.   NATURE

Large-scale public data reuse to model immunotherapy response and resistance

(2020) Jingxin Fu et al.   Genome Medicine

Radiation Exposure–Induced Changes in the Immune Cells and Immune Factors of Mice With or Without Primary Lung Tumor

(2020) Shuxian Pan et al.   Dose-Response

Radiation-induced bystander and abscopal effects: important lessons from preclinical models

(2020) Elisabeth Daguenet et al.   BRITISH JOURNAL OF CANCER

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma

(2020) Sijin Sun et al.   Cancer Medicine

Immunoradiotherapy as an Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent

(2020) Rodolfo Chicas-Sett et al.   Cancers

Analysis of mRNA Expression Patterns in Peripheral Blood Cells of 3 Patients With Cancer After the First Fraction of 2 Gy Irradiation: An Integrated Case Report and Systematic Review

(2019) Yue-Hua Nie et al.   Dose-Response

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia

(2019) Fary Diop et al.   HAEMATOLOGICA

A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas Dataset

(2019) Bum-Sup Jang et al.   Cancer Research and Treatment

Cost–effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA

(2019) Min Huang et al.   Immunotherapy

Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer

(2018) Si-si Wang et al.   Cellular & Molecular Immunology

Limited Role of Promoter Methylation of MGMT and C13ORF18 in Triage of Low-Grade Squamous Intraepithelial Lesion

(2018) Yu-Dong Wang et al.   CHINESE MEDICAL JOURNAL

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

(2018) Jason J. Luke et al.   JOURNAL OF CLINICAL ONCOLOGY

Systemic Therapy for Elderly Patients With Advanced Non–Small-Cell Lung Cancers

(2018) Paul A. Bunn et al.   JOURNAL OF CLINICAL ONCOLOGY

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Rucaparib in ovarian cancer: extending the use of PARP inhibitors in the recurrent disease

(2018) Graziela Z Dal Molin et al.   Future Oncology

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

(2018) Peng Jiang et al.   NATURE MEDICINE

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

(2018) Rodabe N. Amaria et al.   NATURE MEDICINE

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

(2017) Nasser Hanna et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiotherapy and immunotherapy: a beneficial liaison?

(2017) Ralph R. Weichselbaum et al.   Nature Reviews Clinical Oncology

Fads3 modulates docosahexaenoic acid in liver and brain

(2017) Ji Yao Zhang et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer

(2017) Alexandre Ivagnès et al.   OncoImmunology

Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer

(2016) T. Kinoshita et al.   ANNALS OF ONCOLOGY

Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone

(2016) Kristian M. Koller et al.   CANCER BIOLOGY & THERAPY

Genetic Association of PARP15 Polymorphisms with Clinical Outcome of Acute Myeloid Leukemia in a Korean Population

(2016) Min Kyung Lee et al.   Genetic Testing and Molecular Biomarkers

Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer

(2016) Phillip P. Santoiemma et al.   GYNECOLOGIC ONCOLOGY

Strategies to Improve Outcomes of Patients with EGFR-Mutant Non–Small Cell Lung Cancer: Review of the Literature

(2016) Caicun Zhou et al.   Journal of Thoracic Oncology

TLE1 function and therapeutic potential in cancer

(2016) Da Yuan et al.   Oncotarget

Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer

(2016) Dong Wang et al.   Journal of Cancer

B cell regulation of the anti-tumor response and role in carcinogenesis

(2016) Marc Schwartz et al.   Journal for ImmunoTherapy of Cancer

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

(2015) Suzanne L. Topalian et al.   CANCER CELL

Evidence-based Estimates of the Demand for Radiotherapy

(2015) G.P. Delaney et al.   CLINICAL ONCOLOGY

Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer

(2015) Kurt A. Schalper et al.   JNCI-Journal of the National Cancer Institute

Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer

(2015) Kurt A. Schalper et al.   JNCI-Journal of the National Cancer Institute

Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.

(2015) María José Escamez et al.   Oncotarget

Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

(2014) Claire Germain et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin

(2014) Xin Yao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer

(2014) Rafael Guerrero-Preston et al.   Epigenetics

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors

(2014) Liufu Deng et al.   IMMUNITY

Combinations of Immunotherapy and Radiation in Cancer Therapy

(2014) Ralph E. Vatner et al.   Frontiers in Oncology

The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer

(2013) Miriam Lohr et al.   CANCER LETTERS

CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer

(2012) J. S. Nielsen et al.   CLINICAL CANCER RESEARCH

B Cells Contribute to the Antitumor Activity of CpG-Oligodeoxynucleotide in a Mouse Model of Metastatic Lung Carcinoma

(2011) Rosalinda Sorrentino et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity

(2011) R. M. Jones et al.   GUT

cIAP2 Upregulated by E6 Oncoprotein via Epidermal Growth Factor Receptor/Phosphatidylinositol 3-Kinase/AKT Pathway Confers Resistance to Cisplatin in Human Papillomavirus 16/18-Infected Lung Cancer

(2010) H.-H. Wu et al.   CLINICAL CANCER RESEARCH

MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), Amplified on Chromosome 9, Collaborate with p53 Deficiency in Mouse Osteosarcoma Progression

(2009) O. Ma et al.   CANCER RESEARCH

cIAP2 as a therapeutic target in colorectal cancer and other malignancies

(2009) Koh Miura et al.   EXPERT OPINION ON THERAPEUTIC TARGETS